Literature DB >> 22527858

The vasopressin-deficient Brattleboro rat: lessons for the hypothalamo-pituitary-adrenal axis regulation.

Gábor B Makara1, János Varga, István Barna, Ottó Pintér, Barbara Klausz, Dóra Zelena.   

Abstract

Adaptation to stress is indispensable to life and the hypothalamo-pituitary-adrenocortical axis is one of the major components of the adaptation. The hypothalamic component consists of corticotropin-releasing hormone and arginine vasopressin, with a questionable contribution of the latter. Vasopressin was more important in the regulation of the adrenocorticotropin secretion in the perinatal vasopressin-deficient Brattleboro rats than in adulthood, where its role depended on the nature of the stressor encountered. In adults, the vasopressin deficiency did not influence the development of chronic stress response. In the neonatal rats, the role of vasopressin was supported by the inhibitory action of a V1b antagonist and vasopressin antiserum. As the corticosterone response to stress did not follow the adrenocorticotropin levels, we assume the presence of an adrenocorticotropin independent adrenal gland regulation in the neonates. We have shown that the apparent dissociation of the corticosterone and adrenocorticotropin responses is not due to the different time course of the two hormone responses, to different level of the corticosterone binding globulin or to changes in the adrenal gland sensitivity. In vitro experiments point to the contribution of beta-adrenoceptors in the process. It was also confirmed by in vivo tests using the vasopressin-deficient Brattleboro pup as a model organism, where corticosterone levels may rise without adrenocorticotropin level changes. Another important question is the role of adrenocorticotropin beyond the corticosterone secretion regulation, which could be supposed, e.g., in cardiovascular events, immunological processes, and metabolism. We can conclude that Brattleboro rats gave us much information about the stress-axis regulation far beyond the role of vasopressin itself.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22527858     DOI: 10.1007/s10571-012-9842-2

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  64 in total

1.  Pharmacology and Nerve-endings (Walter Ernest Dixon Memorial Lecture): (Section of Therapeutics and Pharmacology).

Authors:  H Dale
Journal:  Proc R Soc Med       Date:  1935-01

2.  [Morphofunctional research on the interrenal gland of the frog Rana temporaria following arginine vasotocin administration].

Authors:  A V Elifanov; A L Polenov; M A Belen'kiĭ; V V Kuzik
Journal:  Zh Evol Biokhim Fiziol       Date:  1988 Sep-Oct

Review 3.  Functional and pharmacological characterization of the first specific agonist and antagonist for the V1b receptor in mammals.

Authors:  Claudine Serradeil-Le Gal; Sylvain Derick; Gabrielle Brossard; Maurice Manning; Jacques Simiand; Rolf Gaillard; Guy Griebel; Gilles Guillon
Journal:  Stress       Date:  2003-09       Impact factor: 3.493

4.  Control of the hypothalamo-pituitary-adrenal axis in the neonatal period: adrenocorticotropin and corticosterone stress responses dissociate in vasopressin-deficient brattleboro rats.

Authors:  Dóra Zelena; Agnes Domokos; István Barna; Zsuzsa Mergl; József Haller; Gábor B Makara
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

5.  Endogenous ACTH, not only alpha-melanocyte-stimulating hormone, reduces food intake mediated by hypothalamic mechanisms.

Authors:  Carla Schulz; Kerstin Paulus; Ralf Lobmann; Mary Dallman; Hendrik Lehnert
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-17       Impact factor: 4.310

Review 6.  Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age.

Authors:  F A Antoni
Journal:  Front Neuroendocrinol       Date:  1993-04       Impact factor: 8.606

7.  Response of the adrenomedullary system to early postnatal stress in the Brattleboro rat.

Authors:  Dóra Zelena; István Barna; Katalin Csabai; Gabriella F Orlando; Gábor B Makara; Mario Engelmann
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

8.  Circadian patterns of stress-induced ACTH secretion are modified by corticosterone responses.

Authors:  W C Engeland; J Shinsako; C M Winget; J Vernikos-Danellis; M F Dallman
Journal:  Endocrinology       Date:  1977-01       Impact factor: 4.736

9.  Characterization of a novel and selective V1B receptor antagonist.

Authors:  Mark Craighead; Rachel Milne; Leigh Campbell-Wan; Lynn Watson; Jeremy Presland; Fiona J Thomson; Hugh M Marston; Clíona P Macsweeney
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

Review 10.  The melanocortin system in control of inflammation.

Authors:  Anna Catania; Caterina Lonati; Andrea Sordi; Andrea Carlin; Patrizia Leonardi; Stefano Gatti
Journal:  ScientificWorldJournal       Date:  2010-09-14
View more
  5 in total

1.  Short-term fluoxetine treatment induces neuroendocrine and behavioral anxiogenic-like responses in adolescent male rats.

Authors:  Francisca Gomez; César Venero; María-Paz Viveros; Luis García-García
Journal:  Exp Brain Res       Date:  2014-12-17       Impact factor: 1.972

Review 2.  Role of mecp2 in experience-dependent epigenetic programming.

Authors:  Christoph A Zimmermann; Anke Hoffmann; Florian Raabe; Dietmar Spengler
Journal:  Genes (Basel)       Date:  2015-03-06       Impact factor: 4.096

Review 3.  Vasopressin V1B Receptor Antagonists as Potential Antidepressants.

Authors:  Shigeyuki Chaki
Journal:  Int J Neuropsychopharmacol       Date:  2021-07-14       Impact factor: 5.176

4.  Stress responsiveness of the hypothalamic-pituitary-adrenal axis: age-related features of the vasopressinergic regulation.

Authors:  Nadezhda D Goncharova
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-12       Impact factor: 5.555

Review 5.  The effect of maternal stress activation on the offspring during lactation in light of vasopressin.

Authors:  Anna Fodor; Dóra Zelena
Journal:  ScientificWorldJournal       Date:  2014-01-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.